Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Garfield

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 29, 2006
Significance of the papillary subtype in relation to durable response to gefitinib in advanced non-small cell lung cancerDavid H Garfield
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Multitargeting ovarian epithelial cancer: adding the old to the newDavid H Garfield
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Modern treatment of lung cancer: case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinomaDavid H Garfield
JAMA|October 13, 2006
Inside baseballDavid H Garfield
Seminars in Oncology|December 16, 2004
Treatment approaches in patients with advanced non-small cell lung cancer and poor performance statusRamaswamy Govindan, David H Garfield
Lung|May 2, 2009
The importance of distinguishing mucinous and nonmucinous bronchioloalveolar carcinomasDavid H Garfield, Jacques Cadranel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Fewer dollars, more senseDavid H Garfield, Aleck Hercbergs
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2011
Dramatic response to pemetrexed in a patient with pneumonic-type mucinous bronchioloalveolar carcinomaDavid H Garfield, Wilbur Franklin
Lung Cancer (Amsterdam, Netherlands)|June 30, 2007
Possible mechanism(s) of action of bortezomib in a patient with bronchioloalveolar carcinomaDavid H Garfield, Jacques L Cadranel
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
Bronchioloalveolar carcinoma: not as easy as "BAC"Howard L West, David H Garfield
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|August 29, 2006
Significance of the papillary subtype in relation to durable response to gefitinib in advanced non-small cell lung cancerDavid H Garfield
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Multitargeting ovarian epithelial cancer: adding the old to the newDavid H Garfield
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Modern treatment of lung cancer: case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinomaDavid H Garfield
JAMA|October 13, 2006
Inside baseballDavid H Garfield
Seminars in Oncology|December 16, 2004
Treatment approaches in patients with advanced non-small cell lung cancer and poor performance statusRamaswamy Govindan, David H Garfield
Lung|May 2, 2009
The importance of distinguishing mucinous and nonmucinous bronchioloalveolar carcinomasDavid H Garfield, Jacques Cadranel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Fewer dollars, more senseDavid H Garfield, Aleck Hercbergs
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2011
Dramatic response to pemetrexed in a patient with pneumonic-type mucinous bronchioloalveolar carcinomaDavid H Garfield, Wilbur Franklin
Lung Cancer (Amsterdam, Netherlands)|June 30, 2007
Possible mechanism(s) of action of bortezomib in a patient with bronchioloalveolar carcinomaDavid H Garfield, Jacques L Cadranel
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
Bronchioloalveolar carcinoma: not as easy as "BAC"Howard L West, David H Garfield
Pageof 4